NeoGenomics Laboratories
NeoGenomics specializes in cancer genetics testing and information services with the most advanced and comprehensive menu of 650+ diagnostic tests covering all key testing methodologies – including broad-panel DNA and RNA-based next-generation sequencing. The RaDaR® assay is a personalized, tumor-informed technology for the detection of minimal residual disease (MRD) and recurrence. Our Pharma Services division works with pharma and biotech partners to help navigate through translational research and global clinical trial testing through FDA filing, launch preparation, and commercialization.